200 related articles for article (PubMed ID: 37397251)
1. Regulation, targets and functions of CSK.
Zhu S; Wang H; Ranjan K; Zhang D
Front Cell Dev Biol; 2023; 11():1206539. PubMed ID: 37397251
[TBL] [Abstract][Full Text] [Related]
2. Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine.
Advani G; Lim YC; Catimel B; Lio DSS; Ng NLY; Chüeh AC; Tran M; Anasir MI; Verkade H; Zhu HJ; Turk BE; Smithgall TE; Ang CS; Griffin M; Cheng HC
Cell Commun Signal; 2017 Aug; 15(1):29. PubMed ID: 28784162
[TBL] [Abstract][Full Text] [Related]
3. C-terminal Src kinase-homologous kinase (CHK), a unique inhibitor inactivating multiple active conformations of Src family tyrosine kinases.
Chong YP; Chan AS; Chan KC; Williamson NA; Lerner EC; Smithgall TE; Bjorge JD; Fujita DJ; Purcell AW; Scholz G; Mulhern TD; Cheng HC
J Biol Chem; 2006 Nov; 281(44):32988-99. PubMed ID: 16959780
[TBL] [Abstract][Full Text] [Related]
4. C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases.
Chong YP; Mulhern TD; Cheng HC
Growth Factors; 2005 Sep; 23(3):233-44. PubMed ID: 16243715
[TBL] [Abstract][Full Text] [Related]
5. Interplay between the tyrosine kinases Chk and Csk and phosphatase PTPRJ is critical for regulating platelets in mice.
Nagy Z; Mori J; Ivanova VS; Mazharian A; Senis YA
Blood; 2020 Apr; 135(18):1574-1587. PubMed ID: 32016283
[TBL] [Abstract][Full Text] [Related]
6. Structural elements and allosteric mechanisms governing regulation and catalysis of CSK-family kinases and their inhibition of Src-family kinases.
Ia KK; Mills RD; Hossain MI; Chan KC; Jarasrassamee B; Jorissen RN; Cheng HC
Growth Factors; 2010 Oct; 28(5):329-50. PubMed ID: 20476842
[TBL] [Abstract][Full Text] [Related]
7. Structure of the carboxyl-terminal Src kinase, Csk.
Ogawa A; Takayama Y; Sakai H; Chong KT; Takeuchi S; Nakagawa A; Nada S; Okada M; Tsukihara T
J Biol Chem; 2002 Apr; 277(17):14351-4. PubMed ID: 11884384
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis regulation by the tyrosine-protein kinase CSK.
Fortner A; Chera A; Tanca A; Bucur O
Front Cell Dev Biol; 2022; 10():1078180. PubMed ID: 36578781
[TBL] [Abstract][Full Text] [Related]
9. A novel non-catalytic mechanism employed by the C-terminal Src-homologous kinase to inhibit Src-family kinase activity.
Chong YP; Mulhern TD; Zhu HJ; Fujita DJ; Bjorge JD; Tantiongco JP; Sotirellis N; Lio DS; Scholz G; Cheng HC
J Biol Chem; 2004 May; 279(20):20752-66. PubMed ID: 14985335
[TBL] [Abstract][Full Text] [Related]
10. Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases.
Chong YP; Ia KK; Mulhern TD; Cheng HC
Biochim Biophys Acta; 2005 Dec; 1754(1-2):210-20. PubMed ID: 16198159
[TBL] [Abstract][Full Text] [Related]
11. Defining the substrate specificity determinants recognized by the active site of C-terminal Src kinase-homologous kinase (CHK) and identification of β-synuclein as a potential CHK physiological substrate.
Ia KK; Jeschke GR; Deng Y; Kamaruddin MA; Williamson NA; Scanlon DB; Culvenor JG; Hossain MI; Purcell AW; Liu S; Zhu HJ; Catimel B; Turk BE; Cheng HC
Biochemistry; 2011 Aug; 50(31):6667-77. PubMed ID: 21699177
[TBL] [Abstract][Full Text] [Related]
12. Novel mechanism of regulation of the non-receptor protein tyrosine kinase Csk: insights from NMR mapping studies and site-directed mutagenesis.
Shekhtman A; Ghose R; Wang D; Cole PA; Cowburn D
J Mol Biol; 2001 Nov; 314(1):129-38. PubMed ID: 11724538
[TBL] [Abstract][Full Text] [Related]
13. Domain interactions in protein tyrosine kinase Csk.
Sondhi D; Cole PA
Biochemistry; 1999 Aug; 38(34):11147-55. PubMed ID: 10460171
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the SRC family kinases by Csk.
Okada M
Int J Biol Sci; 2012; 8(10):1385-97. PubMed ID: 23139636
[TBL] [Abstract][Full Text] [Related]
15. Development of the procedures for high-yield expression and rapid purification of active recombinant Csk-homologous kinase (CHK): comparison of the catalytic activities of CHK and CSK.
Chan KC; Lio DS; Dobson RC; Jarasrassamee B; Hossain MI; Roslee AK; Ia KK; Perugini MA; Cheng HC
Protein Expr Purif; 2010 Dec; 74(2):139-47. PubMed ID: 20667476
[TBL] [Abstract][Full Text] [Related]
16. CSK-homologous kinase (CHK/MATK) is a potential colorectal cancer tumour suppressor gene epigenetically silenced by promoter methylation.
Chüeh AC; Advani G; Foroutan M; Smith J; Ng N; Nandurkar H; Lio DS; Zhu HJ; Chong YP; Verkade H; Fujita DJ; Bjorge J; Basheer F; Lim JP; Luk I; Dhillon A; Sakthianandeswaren A; Mouradov D; Sieber O; Hollande F; Mariadason JM; Cheng HC
Oncogene; 2021 Apr; 40(17):3015-3029. PubMed ID: 33767439
[TBL] [Abstract][Full Text] [Related]
17. Regulation, targets and functions of CHK.
Zhu S; Sun R; Guo X; Bao Y; Zhang D
Front Cell Dev Biol; 2022; 10():1068952. PubMed ID: 36568988
[TBL] [Abstract][Full Text] [Related]
18. Src family kinases: regulation of their activities, levels and identification of new pathways.
Ingley E
Biochim Biophys Acta; 2008 Jan; 1784(1):56-65. PubMed ID: 17905674
[TBL] [Abstract][Full Text] [Related]
19. Mammalian Pragmin regulates Src family kinases via the Glu-Pro-Ile-Tyr-Ala (EPIYA) motif that is exploited by bacterial effectors.
Safari F; Murata-Kamiya N; Saito Y; Hatakeyama M
Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14938-43. PubMed ID: 21873224
[TBL] [Abstract][Full Text] [Related]
20. Functional diversity of Csk, Chk, and Src SH2 domains due to a single residue variation.
Ayrapetov MK; Nam NH; Ye G; Kumar A; Parang K; Sun G
J Biol Chem; 2005 Jul; 280(27):25780-7. PubMed ID: 15890649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]